NIAID Funding News, November 20, 2024

November 20, 2024 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-11-20 Feature Articles  How to Use the World's Largest Public Clinical Trials Registry as a Resource While many researchers treat ClinicalTrials.gov only as a repository to submit required study information, it's also worth thinking of it as an extensive online library. Opportunities and Resources Combat Antibiotic Resistance Through Phage Therapy Research Propose a multidisciplinary research group that will implement phage therapeutic research by focusing on preclinical development and studying pharmacokinetics and pharmacodynamics. Investigate Understudied Proteins Associated with Rare Diseases Gather preliminary data around the role of understudied proteins associated with rare diseases and characterize new targets for treatment of human disease among them. Conduct Translational Exploratory Research on Chemical Countermeasures Research civilian chemical medical countermeasures and novel treatment strategies to combat serious morbidity and mortality resulting from high consequence public health chemical emergencies. In The News Replication as a Pathway to Reproducibility in Research A new initiative will support efforts to independently replicate significant lines of research and validate novel technologies across different scientific research areas in preclinical, translational, and technology development studies. News Briefs and Worth Repeating Note an Addendum to NIAID's Financial Management Plan for FY 2025 HHS ASPR Posts FAQs on DURC/PEPP Policy New Scientific Integrity Policies Focus on Public Trust Advice Corner Small Business Applicants—Know Your Actual Budget Cap The Small Business Administration (SBA) sets caps for total costs on small business grant awards for all federal agencies, above which an agency must request SBA approval. Reader Questions "I'd like to apply for an R21, but I think I'll need a bigger budget and longer project period. What should I do?" "Can I submit the same research project as an R01 application and an R21 application simultaneously?" New Funding Opportunities PAR-25-111, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21, Clinical Trial Optional) PAR-25-110, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01, Clinical Trial Optional) PA-25-168, Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) NOT-CA-25-003, Notice of Special Interest (NOSI): Implementation Science for Climate Change and Health Find other announcements at NIAID Opportunities and Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107